IRON SUCROSE

IRON SUCROSE was reported 9663 times

IRON SUCROSE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VESSEL PUNCTURE SITE INFLAMMATION 9 0.2308
1 ANORECTAL ULCER 8 0.2222
2 NON-CONSUMMATION 8 0.1081
3 SHUNT STENOSIS 23 0.0830
4 HAEMODIALYSIS COMPLICATION 10 0.0588
5 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 14 0.0558
6 ADMINISTRATION SITE DISCOLOURATION 6 0.0480
7 GRANULOMA SKIN 39 0.0475
8 SHUNT OCCLUSION 24 0.0472
9 INFUSION SITE PHLEBITIS 9 0.0395
10 AGONAL RESPIRATION 11 0.0389
11 INJECTION SITE PHLEBITIS 9 0.0385
12 EXTRAVASATION 149 0.0362
13 SUPERFICIAL VEIN THROMBOSIS 28 0.0333
14 TRANSFERRIN SATURATION INCREASED 11 0.0320
15 LOSS OF EMPLOYMENT 94 0.0311
16 INFUSION SITE DISCOLOURATION 27 0.0307
17 INFUSION SITE THROMBOSIS 8 0.0299
18 NEPHROGENIC SYSTEMIC FIBROSIS 88 0.0291
19 BLOOD PARATHYROID HORMONE DECREASED 42 0.0283
20 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 29 0.0273
21 IRON OVERLOAD 29 0.0269
22 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 10 0.0267
23 SKIN FIBROSIS 12 0.0248
24 HYPOPHOSPHATAEMIC OSTEOMALACIA 6 0.0227
25 HYPERPARATHYROIDISM SECONDARY 57 0.0227
26 EXTREMITY CONTRACTURE 14 0.0219
27 INTRAVASCULAR HAEMOLYSIS 12 0.0214
28 ARTERIOVENOUS FISTULA THROMBOSIS 7 0.0202
29 DIALYSIS RELATED COMPLICATION 7 0.0198
30 JOINT CONTRACTURE 21 0.0196
31 BACTERIAL TRANSLOCATION 6 0.0189
32 TRANSFERRIN SATURATION DECREASED 8 0.0187
33 C-REACTIVE PROTEIN DECREASED 12 0.0184
34 SKIN INDURATION 38 0.0183
35 INJECTION SITE THROMBOSIS 6 0.0183
36 INFUSION SITE OEDEMA 15 0.0179
37 SERUM FERRITIN DECREASED 29 0.0168
38 PANNICULITIS 40 0.0165
39 ANGIODYSPLASIA 6 0.0165
40 NEPHROGENIC ANAEMIA 75 0.0162
41 LIVEDO RETICULARIS 33 0.0158
42 APLASIA PURE RED CELL 54 0.0157
43 SKIN HYPERTROPHY 41 0.0146
44 RHEUMATOID NODULE 40 0.0145
45 THROMBOPHLEBITIS SUPERFICIAL 43 0.0142
46 DRUG TOLERANCE DECREASED 39 0.0139
47 PORPHYRIA NON-ACUTE 6 0.0138
48 SERRATIA INFECTION 10 0.0134
49 LYMPHANGITIS 10 0.0124
50 ANAPHYLACTOID REACTION 50 0.0121
51 DISCOLOURED VOMIT 11 0.0114
52 PROTHROMBIN TIME RATIO DECREASED 7 0.0112
53 GASTROINTESTINAL SCARRING 8 0.0110
54 SKIN TIGHTNESS 51 0.0108
55 INFUSION SITE URTICARIA 7 0.0104
56 MARROW HYPERPLASIA 7 0.0103
57 INDUCED LABOUR 6 0.0101
58 ARTERIOVENOUS FISTULA SITE COMPLICATION 6 0.0100
59 FOETAL HYPOKINESIA 7 0.0100
60 CALCIPHYLAXIS 18 0.0098
61 INFUSION SITE EXTRAVASATION 58 0.0093
62 BREATH SOUNDS ABNORMAL 44 0.0089
63 IRON DEFICIENCY 40 0.0089
64 FIBROSIS 27 0.0088
65 SERUM FERRITIN INCREASED 46 0.0087
66 PULSE ABSENT 41 0.0086
67 BLOOD IRON INCREASED 16 0.0085
68 PHLEBITIS 43 0.0084
69 VEIN RUPTURE 14 0.0084
70 SEIZURE LIKE PHENOMENA 14 0.0082
71 INFUSION SITE WARMTH 10 0.0082
72 BLOOD BILIRUBIN DECREASED 5 0.0081
73 SKIN NECROSIS 42 0.0081
74 CHORIORETINITIS 5 0.0078
75 INCISION SITE PAIN 9 0.0077
76 RHEUMATOID FACTOR POSITIVE 44 0.0076
77 TOXOPLASMOSIS 8 0.0074
78 HEPATIC STEATOSIS 136 0.0073
79 UNRESPONSIVE TO STIMULI 185 0.0072
80 PULSE ABNORMAL 17 0.0071
81 PREMATURE RUPTURE OF MEMBRANES 17 0.0070
82 INCORRECT DRUG ADMINISTRATION RATE 30 0.0070
83 ADMINISTRATION SITE EXTRAVASATION 7 0.0070
84 INFUSION RELATED REACTION 463 0.0070
85 BLOOD PHOSPHORUS INCREASED 19 0.0070
86 BICYTOPENIA 13 0.0066
87 BLOOD PRESSURE IMMEASURABLE 10 0.0065
88 BLOOD PARATHYROID HORMONE INCREASED 19 0.0065
89 XEROSIS 8 0.0065
90 FEMALE GENITAL TRACT FISTULA 11 0.0064
91 INFUSION SITE PAIN 82 0.0064
92 HYPOPHOSPHATAEMIA 47 0.0064
93 DRUG MONITORING PROCEDURE NOT PERFORMED 11 0.0061
94 THROMBOPHLEBITIS 21 0.0060
95 END STAGE RENAL DISEASE 108 0.0059
96 OSTEOMALACIA 9 0.0058
97 UTERINE CONTRACTIONS DURING PREGNANCY 6 0.0058
98 IRON DEFICIENCY ANAEMIA 53 0.0057
99 INCORRECT PRODUCT ADMINISTRATION DURATION 123 0.0057
100 HYPERPHOSPHATAEMIA 12 0.0056
101 INFUSION SITE SWELLING 35 0.0056
102 RESUSCITATION 9 0.0054
103 VENOUS THROMBOSIS 21 0.0053
104 HYPERPARATHYROIDISM 11 0.0053
105 VENOUS THROMBOSIS LIMB 11 0.0053
106 ADMINISTRATION SITE PAIN 6 0.0052
107 BLOOD PHOSPHORUS DECREASED 19 0.0052
108 CONTRAINDICATED PRODUCT ADMINISTERED 155 0.0051
109 CLOSTRIDIUM TEST POSITIVE 10 0.0045
110 LARGE INTESTINAL STENOSIS 9 0.0045
111 MUSCLE CONTRACTURE 9 0.0044
112 INFUSION SITE RASH 6 0.0044
113 PERITONEAL CLOUDY EFFLUENT 6 0.0044
114 CARBON DIOXIDE DECREASED 5 0.0043
115 NORMOCHROMIC NORMOCYTIC ANAEMIA 13 0.0043
116 PALLOR 116 0.0043
117 INJECTION SITE OEDEMA 7 0.0041
118 MIXED LIVER INJURY 12 0.0040
119 RED BLOOD CELL SEDIMENTATION RATE INCREASED 44 0.0040
120 SMALL INTESTINAL HAEMORRHAGE 8 0.0040
121 HYPERCALCAEMIA 49 0.0040
122 PRODUCT PREPARATION ISSUE 26 0.0040
123 PARAPARESIS 7 0.0039
124 PREMATURE SEPARATION OF PLACENTA 6 0.0039
125 NEOPLASM SKIN 6 0.0039
126 INTESTINAL ULCER 6 0.0038
127 HAEMOLYSIS 29 0.0038
128 STARING 9 0.0037
129 INFUSION SITE ERYTHEMA 31 0.0037
130 OXYGEN THERAPY 6 0.0036
131 BLOOD CALCIUM ABNORMAL 6 0.0036
132 RENAL TRANSPLANT 13 0.0036
133 HAEMODIALYSIS 30 0.0036
134 COMPLICATIONS OF TRANSPLANTED KIDNEY 8 0.0035
135 THERAPEUTIC PRODUCT EFFECT DECREASED 157 0.0035
136 INFUSION SITE PRURITUS 11 0.0035
137 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 27 0.0035
138 METHAEMOGLOBINAEMIA 8 0.0035
139 HYPERVENTILATION 20 0.0034
140 RENAL FAILURE CHRONIC 26 0.0034
141 INDURATION 6 0.0034
142 BODY TEMPERATURE FLUCTUATION 7 0.0034
143 ABDOMINAL MASS 9 0.0034
144 CEREBRAL HAEMATOMA 11 0.0033
145 PREMATURE DELIVERY 52 0.0033
146 PNEUMONIA KLEBSIELLA 6 0.0033
147 FEELING HOT 200 0.0033
148 CYANOSIS 51 0.0032
149 INFUSION SITE BRUISING 7 0.0032
150 BLOOD PRESSURE DECREASED 215 0.0032
151 INFLAMMATORY MARKER INCREASED 16 0.0032
152 DEFORMITY 30 0.0032
153 POLYP 21 0.0032
154 BURNING SENSATION 224 0.0032
155 SYSTEMIC CANDIDA 8 0.0032
156 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 13 0.0032
157 AORTIC STENOSIS 11 0.0032
158 BLOOD IRON DECREASED 37 0.0031
159 ANAPHYLACTIC REACTION 172 0.0031
160 SKIN DISCOLOURATION 141 0.0031
161 RESPIRATORY DISTRESS 84 0.0030
162 CYTOLYTIC HEPATITIS 10 0.0030
163 BLOOD CULTURE POSITIVE 9 0.0030
164 METABOLIC ENCEPHALOPATHY 9 0.0030
165 VEIN DISORDER 15 0.0030
166 POTENTIATING DRUG INTERACTION 10 0.0030
167 URTICARIA 495 0.0030
168 ULCER 47 0.0030
169 HAEMOGLOBIN ABNORMAL 19 0.0030
170 PAINFUL RESPIRATION 7 0.0029
171 BLOOD ALBUMIN DECREASED 23 0.0029
172 DIALYSIS 41 0.0029
173 BASAL CELL CARCINOMA 45 0.0029
174 HYPOPNOEA 10 0.0029
175 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 11 0.0029
176 BLOOD PRESSURE SYSTOLIC DECREASED 13 0.0029
177 THROAT TIGHTNESS 76 0.0028
178 PEMPHIGOID 21 0.0028
179 LUNG CANCER METASTATIC 8 0.0028
180 LOW BIRTH WEIGHT BABY 22 0.0028
181 FLUID OVERLOAD 40 0.0027
182 DIABETIC NEPHROPATHY 6 0.0027
183 PRODUCT AVAILABILITY ISSUE 62 0.0027
184 PRESYNCOPE 66 0.0027
185 INFUSION SITE REACTION 8 0.0027
186 LARGE INTESTINAL HAEMORRHAGE 6 0.0027
187 ADENOCARCINOMA OF COLON 5 0.0027
188 PULMONARY FIBROSIS 51 0.0027
189 HYPOTENSION 529 0.0026
190 HYPERVOLAEMIA 13 0.0026
191 HYPERTHERMIA 20 0.0026
192 INTERNATIONAL NORMALISED RATIO ABNORMAL 9 0.0026
193 ANAL FISSURE 14 0.0026
194 FLUSHING 265 0.0026
195 HAEMANGIOMA 6 0.0026
196 LOCALISED OEDEMA 12 0.0026
197 RESPIRATORY RATE INCREASED 23 0.0026
198 ERYTHEMA NODOSUM 9 0.0026
199 JOINT STIFFNESS 67 0.0026
200 COLD SWEAT 45 0.0026
201 JOINT RANGE OF MOTION DECREASED 34 0.0025
202 FAECAL CALPROTECTIN INCREASED 8 0.0025
203 RASH MORBILLIFORM 7 0.0025
204 DEVICE RELATED SEPSIS 5 0.0025
205 DRUG ERUPTION 44 0.0025
206 VITAMIN B12 DEFICIENCY 10 0.0025
207 PERIPHERAL SWELLING 378 0.0025
208 SKIN ULCER 63 0.0024
209 HYPOCALCAEMIA 46 0.0024
210 CHEST DISCOMFORT 246 0.0024
211 STRIDOR 7 0.0024
212 FLANK PAIN 22 0.0023
213 ABSCESS LIMB 10 0.0023
214 FOETAL DEATH 12 0.0023
215 HEPATIC LESION 10 0.0023
216 TACHYCARDIA 205 0.0023
217 PRESCRIBED UNDERDOSE 46 0.0023
218 FOETAL GROWTH RESTRICTION 14 0.0023
219 CEREBELLAR SYNDROME 5 0.0023
220 SKIN PLAQUE 19 0.0023
221 MATERNAL EXPOSURE DURING PREGNANCY 200 0.0022
222 HYPERLACTACIDAEMIA 6 0.0022
223 MALNUTRITION 25 0.0022
224 CAESAREAN SECTION 26 0.0022
225 DIVERTICULUM INTESTINAL HAEMORRHAGIC 5 0.0022
226 POOR VENOUS ACCESS 23 0.0022
227 MUSCLE TIGHTNESS 36 0.0022
228 SYNOVITIS 40 0.0022
229 ABDOMINAL TENDERNESS 11 0.0022
230 PERITONITIS BACTERIAL 22 0.0022
231 ACUTE CORONARY SYNDROME 18 0.0022
232 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
233 GASTRITIS EROSIVE 10 0.0021
234 C-REACTIVE PROTEIN INCREASED 78 0.0021
235 CARDIAC FAILURE CONGESTIVE 172 0.0021
236 ACUTE PULMONARY OEDEMA 12 0.0021
237 PERIORBITAL OEDEMA 11 0.0021
238 KIDNEY TRANSPLANT REJECTION 10 0.0021
239 FIBULA FRACTURE 6 0.0021
240 OEDEMA PERIPHERAL 253 0.0021
241 FAECES DISCOLOURED 45 0.0021
242 STILLBIRTH 10 0.0021
243 HYPERHIDROSIS 266 0.0021
244 DIVERTICULUM INTESTINAL 9 0.0021
245 GENERALISED OEDEMA 25 0.0020
246 FIBRIN D DIMER INCREASED 7 0.0020
247 ATELECTASIS 19 0.0020
248 HYPERSENSITIVITY 365 0.0020
249 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
250 GASTRIC DISORDER 67 0.0020
251 PARAESTHESIA 307 0.0019
252 ENDOCARDITIS 10 0.0019
253 DEVICE RELATED INFECTION 30 0.0019
254 BLOOD PRESSURE SYSTOLIC INCREASED 38 0.0019
255 RASH MACULO-PAPULAR 43 0.0019
256 PERITONITIS 40 0.0019
257 DIARRHOEA HAEMORRHAGIC 18 0.0019
258 COMPARTMENT SYNDROME 5 0.0019
259 MALABSORPTION 10 0.0019
260 ARTERIOSCLEROSIS 18 0.0019
261 ENTEROCOLITIS 11 0.0019
262 CHROMATURIA 43 0.0019
263 HAEMOGLOBIN DECREASED 195 0.0019
264 EYE MOVEMENT DISORDER 13 0.0019
265 LIVER DISORDER 84 0.0019
266 SKIN WARM 11 0.0019
267 SUPRAVENTRICULAR TACHYCARDIA 18 0.0019
268 POOR PERIPHERAL CIRCULATION 8 0.0019
269 LUNG NEOPLASM 8 0.0019
270 SYNCOPE 185 0.0018
271 REFUSAL OF TREATMENT BY PATIENT 12 0.0018
272 HEPATIC ENZYME INCREASED 124 0.0018
273 GASTROINTESTINAL SOUNDS ABNORMAL 9 0.0018
274 INJECTION SITE INFLAMMATION 9 0.0018
275 DYSPNOEA 1015 0.0018
276 CLOSTRIDIUM DIFFICILE COLITIS 19 0.0018
277 ANAPHYLACTIC SHOCK 46 0.0018
278 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 9 0.0018
279 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
280 OESOPHAGEAL CANDIDIASIS 7 0.0018
281 HAEMOGLOBIN INCREASED 8 0.0018
282 BRONCHOPNEUMONIA 6 0.0018
283 SKIN HYPERPIGMENTATION 15 0.0017
284 PYELONEPHRITIS 15 0.0017
285 DYSPNOEA AT REST 5 0.0017
286 UMBILICAL HERNIA 8 0.0017
287 ABDOMINAL PAIN 397 0.0017
288 LOGORRHOEA 6 0.0017
289 INJECTION SITE EXTRAVASATION 21 0.0017
290 PRURITUS 651 0.0017
291 SCAR 29 0.0017
292 CARDIAC FAILURE 135 0.0017
293 PERIPHERAL COLDNESS 23 0.0017
294 ANAL ABSCESS 9 0.0017
295 FAECAL INCONTINENCE 8 0.0017
296 ERYTHEMA 342 0.0017
297 LOSS OF CONSCIOUSNESS 213 0.0017
298 DRUG INTOLERANCE 160 0.0017
299 BONE MARROW DISORDER 5 0.0017
300 CHILLS 194 0.0017
301 HEART RATE DECREASED 58 0.0017
302 THERAPEUTIC RESPONSE DECREASED 100 0.0016
303 FEBRILE BONE MARROW APLASIA 7 0.0016
304 HYPERTENSION 348 0.0016
305 ASTHMATIC CRISIS 6 0.0016
306 EXPOSURE DURING PREGNANCY 102 0.0016
307 FOOD INTOLERANCE 6 0.0016
308 PHARYNGEAL SWELLING 16 0.0016
309 CARDIAC ARREST 135 0.0016
310 RESPIRATORY ARREST 45 0.0016
311 DIASTOLIC DYSFUNCTION 5 0.0016
312 OCULAR ICTERUS 7 0.0016
313 BACTERAEMIA 19 0.0016
314 PROTEIN TOTAL DECREASED 6 0.0016
315 CATHETER SITE INFECTION 6 0.0016
316 PARANASAL SINUS DISCOMFORT 6 0.0016
317 GASTRIC ULCER 30 0.0016
318 CHEST PAIN 291 0.0016
319 MATERNAL DRUGS AFFECTING FOETUS 12 0.0016
320 NEUTROPHIL COUNT INCREASED 16 0.0016
321 PERIPHERAL VASCULAR DISORDER 8 0.0016
322 SENSATION OF FOREIGN BODY 13 0.0015
323 FAILURE TO THRIVE 8 0.0015
324 ANTINUCLEAR ANTIBODY POSITIVE 5 0.0015
325 HEPATITIS 39 0.0015
326 INJECTION SITE DISCOLOURATION 19 0.0015
327 PSEUDOMONAS INFECTION 13 0.0015
328 ARTERIOSPASM CORONARY 6 0.0015
329 ANAEMIA 285 0.0015
330 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
331 BACK PAIN 346 0.0015
332 CHRONIC KIDNEY DISEASE 112 0.0015
333 PRE-ECLAMPSIA 7 0.0015
334 GESTATIONAL DIABETES 7 0.0015
335 LARYNGEAL OEDEMA 9 0.0015
336 CARDIO-RESPIRATORY ARREST 61 0.0015
337 LEG AMPUTATION 6 0.0015
338 ACUTE RESPIRATORY FAILURE 28 0.0015
339 HUMERUS FRACTURE 7 0.0015
340 ENTEROCOCCAL INFECTION 7 0.0014
341 ANAL INCONTINENCE 13 0.0014
342 HEART RATE ABNORMAL 8 0.0014
343 CAROTID ARTERY STENOSIS 5 0.0014
344 EOSINOPHILIA 25 0.0014
345 FISTULA 16 0.0014
346 LIMB DISCOMFORT 44 0.0014
347 MUSCULOSKELETAL STIFFNESS 124 0.0014
348 CIRCULATORY COLLAPSE 24 0.0014
349 DIVERTICULUM 10 0.0014
350 RETCHING 30 0.0014
351 BRONCHOSPASM 20 0.0014
352 FEELING COLD 39 0.0014
353 NEPHROPATHY 13 0.0014
354 PRURITUS GENERALISED 30 0.0014
355 DRUG SPECIFIC ANTIBODY PRESENT 9 0.0014
356 OEDEMA 75 0.0014
357 CARDIOMEGALY 17 0.0014
358 TOOTH INJURY 6 0.0014
359 STAPHYLOCOCCAL BACTERAEMIA 6 0.0014
360 DRUG LEVEL DECREASED 14 0.0014
361 BLOOD PRESSURE FLUCTUATION 33 0.0014
362 VOMITING 646 0.0014
363 RASH MACULAR 48 0.0014
364 PERITONEAL DIALYSIS COMPLICATION 10 0.0014
365 PREMATURE BABY 41 0.0014
366 LYMPHOCYTE COUNT DECREASED 24 0.0014
367 INFLAMMATION 70 0.0014
368 HEART RATE INCREASED 133 0.0013
369 WRONG PRODUCT ADMINISTERED 9 0.0013
370 JOINT SWELLING 160 0.0013
371 PRODUCT QUALITY ISSUE 180 0.0013
372 VASCULAR DEVICE INFECTION 6 0.0013
373 BODY TEMPERATURE DECREASED 13 0.0013
374 PARAESTHESIA ORAL 19 0.0013
375 TROPONIN INCREASED 10 0.0013
376 ECCHYMOSIS 9 0.0013
377 NAUSEA 1035 0.0013
378 HYPOTONIA 13 0.0013
379 FORMICATION 9 0.0013
380 THROAT IRRITATION 58 0.0013
381 APNOEA 10 0.0013
382 DEFAECATION URGENCY 9 0.0013
383 ADVERSE REACTION 17 0.0013
384 FAECALOMA 7 0.0013
385 MOTOR DYSFUNCTION 13 0.0013
386 HAEMATOMA 33 0.0013
387 DRUG LEVEL BELOW THERAPEUTIC 7 0.0013
388 ABDOMINAL DISCOMFORT 212 0.0013
389 OXYGEN SATURATION DECREASED 71 0.0013
390 RASH 550 0.0013
391 HAEMATOCRIT DECREASED 25 0.0013
392 ECONOMIC PROBLEM 19 0.0013
393 ILL-DEFINED DISORDER 76 0.0012
394 TACHYPNOEA 17 0.0012
395 C-REACTIVE PROTEIN ABNORMAL 8 0.0012
396 PETECHIAE 13 0.0012
397 PROCTALGIA 8 0.0012
398 PURPURA 11 0.0012
399 ANGINA UNSTABLE 8 0.0012
400 INCONTINENCE 13 0.0012
401 GASTROINTESTINAL DISORDER 110 0.0012
402 GASTROINTESTINAL INFECTION 11 0.0012
403 HEAVY MENSTRUAL BLEEDING 11 0.0012
404 ACUTE MYOCARDIAL INFARCTION 36 0.0012
405 PANCREATIC DISORDER 6 0.0012
406 HAEMATOCHEZIA 67 0.0012
407 APPETITE DISORDER 8 0.0012
408 EXOSTOSIS 11 0.0012
409 ABDOMINAL PAIN UPPER 248 0.0012
410 SKIN LESION 33 0.0012
411 HYPOVOLAEMIA 7 0.0012
412 LIVE BIRTH 10 0.0012
413 DEPRESSED LEVEL OF CONSCIOUSNESS 47 0.0012
414 ACIDOSIS 9 0.0012
415 BODY TEMPERATURE INCREASED 24 0.0012
416 MATERNAL EXPOSURE BEFORE PREGNANCY 8 0.0012
417 MUSCULOSKELETAL CHEST PAIN 18 0.0012
418 RASH PRURITIC 63 0.0012
419 INGUINAL HERNIA 7 0.0011
420 PLATELET COUNT INCREASED 15 0.0011
421 LOCAL SWELLING 20 0.0011
422 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
423 URINE OUTPUT DECREASED 10 0.0011
424 ANHEDONIA 30 0.0011
425 RECTAL HAEMORRHAGE 49 0.0011
426 BLOOD PRESSURE INCREASED 174 0.0011
427 BLOOD UREA INCREASED 19 0.0011
428 SUDDEN DEATH 12 0.0011
429 LUNG INFILTRATION 10 0.0011
430 AGRANULOCYTOSIS 21 0.0011
431 VITAMIN D DEFICIENCY 11 0.0011
432 SINUS TACHYCARDIA 16 0.0011
433 SENSORY DISTURBANCE 18 0.0011
434 SWOLLEN TONGUE 35 0.0011
435 SECRETION DISCHARGE 14 0.0011
436 POST PROCEDURAL HAEMORRHAGE 13 0.0011
437 STRESS FRACTURE 6 0.0011
438 ANGIOEDEMA 49 0.0011
439 ARTHRALGIA 459 0.0011
440 SWELLING 103 0.0011
441 HEPATIC CYTOLYSIS 14 0.0011
442 ARTHROPATHY 61 0.0011
443 GASTROENTERITIS 16 0.0011
444 ASPARTATE AMINOTRANSFERASE INCREASED 58 0.0011
445 EMBOLISM 9 0.0011
446 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
447 HYPOKALAEMIA 50 0.0011
448 HYPERTENSIVE CRISIS 12 0.0011
449 HEPATITIS ACUTE 7 0.0011
450 HAEMORRHOIDS 21 0.0011
451 FREQUENT BOWEL MOVEMENTS 29 0.0011
452 DEAFNESS 28 0.0011
453 RASH PAPULAR 24 0.0011
454 THIRST 19 0.0011
455 COLECTOMY 6 0.0011
456 PREMATURE LABOUR 6 0.0011
457 MALAISE 464 0.0011
458 BLOOD PRESSURE ABNORMAL 21 0.0011
459 BRADYCARDIA 56 0.0011
460 COLITIS ULCERATIVE 47 0.0011
461 HYPOXIA 37 0.0010
462 MICTURITION URGENCY 12 0.0010
463 ILEUS 13 0.0010
464 DIZZINESS 521 0.0010
465 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 50 0.0010
466 MOUTH SWELLING 6 0.0010
467 SEPTIC SHOCK 45 0.0010
468 COUGH 290 0.0010
469 METABOLIC DISORDER 6 0.0010
470 ELECTROLYTE IMBALANCE 12 0.0010
471 RENAL FAILURE 137 0.0010
472 APHTHOUS ULCER 8 0.0010
473 SWELLING FACE 67 0.0010
474 PULMONARY OEDEMA 46 0.0010
475 PLEURAL EFFUSION 62 0.0010
476 RESPIRATION ABNORMAL 7 0.0010
477 WRONG DRUG ADMINISTERED 9 0.0010
478 HYPOAESTHESIA 151 0.0010
479 CARDIAC PACEMAKER INSERTION 6 0.0010
480 OROPHARYNGEAL DISCOMFORT 9 0.0010
481 HYPOAESTHESIA ORAL 15 0.0010
482 LEUKOCYTOSIS 18 0.0010
483 CORONARY ARTERY STENOSIS 5 0.0010
484 TOXIC SKIN ERUPTION 10 0.0010
485 LIP SWELLING 33 0.0010
486 VENTRICULAR FIBRILLATION 11 0.0010
487 TOXIC EPIDERMAL NECROLYSIS 15 0.0010
488 VULVOVAGINAL BURNING SENSATION 6 0.0010
489 ASPHYXIA 8 0.0010
490 SMALL INTESTINAL OBSTRUCTION 12 0.0010
491 HYPERAESTHESIA 8 0.0010
492 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
493 CACHEXIA 5 0.0010
494 PIGMENTATION DISORDER 6 0.0010
495 DERMATITIS BULLOUS 7 0.0010
496 HEPATIC ENCEPHALOPATHY 9 0.0010
497 WHITE BLOOD CELL COUNT INCREASED 37 0.0010
498 PRODUCT USE ISSUE 181 0.0010
499 ALANINE AMINOTRANSFERASE INCREASED 59 0.0010
500 ATRIAL FIBRILLATION 93 0.0010
501 TRANSFUSION 10 0.0010
502 CELLULITIS 48 0.0010
503 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
504 URINARY INCONTINENCE 28 0.0009
505 RENAL PAIN 10 0.0009
506 ARTHRITIS 74 0.0009
507 ANORECTAL DISCOMFORT 5 0.0009
508 GASTROINTESTINAL HAEMORRHAGE 78 0.0009
509 MOBILITY DECREASED 67 0.0009
510 CARDIAC FLUTTER 6 0.0009
511 HYSTERECTOMY 8 0.0009
512 HAEMODYNAMIC INSTABILITY 7 0.0009
513 RENAL TUBULAR NECROSIS 9 0.0009
514 SHOCK 21 0.0009
515 GASTRITIS 24 0.0009
516 GRIP STRENGTH DECREASED 8 0.0009
517 RENAL INJURY 27 0.0009
518 MELAENA 20 0.0009
519 SARS-COV-2 TEST POSITIVE 12 0.0009
520 MENTAL STATUS CHANGES 25 0.0009
521 POST-TRAUMATIC STRESS DISORDER 6 0.0009
522 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
523 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
524 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
525 CORONARY ARTERY DISEASE 27 0.0009
526 COLITIS ISCHAEMIC 6 0.0009
527 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
528 MITRAL VALVE INCOMPETENCE 10 0.0009
529 TRICUSPID VALVE INCOMPETENCE 7 0.0009
530 SEPSIS 98 0.0009
531 ABSCESS 14 0.0009
532 NEPHROTIC SYNDROME 6 0.0009
533 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15 0.0009
534 TEMPERATURE INTOLERANCE 9 0.0009
535 UROSEPSIS 8 0.0009
536 PERICARDIAL EFFUSION 20 0.0009
537 LARGE INTESTINE PERFORATION 6 0.0009
538 RESPIRATORY FAILURE 63 0.0009
539 HYPOMAGNESAEMIA 12 0.0009
540 DIARRHOEA 555 0.0009
541 MASS 12 0.0009
542 RIGHT VENTRICULAR FAILURE 6 0.0009
543 ABNORMAL FAECES 7 0.0009
544 SPLENOMEGALY 10 0.0009
545 PYREXIA 294 0.0008
546 VENTRICULAR TACHYCARDIA 14 0.0008
547 PALPITATIONS 99 0.0008
548 COLITIS 32 0.0008
549 ATAXIA 10 0.0008
550 RASH ERYTHEMATOUS 40 0.0008
551 CHOLESTASIS 16 0.0008
552 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
553 SINUS BRADYCARDIA 8 0.0008
554 ACUTE KIDNEY INJURY 126 0.0008
555 WHEEZING 48 0.0008
556 IMPAIRED GASTRIC EMPTYING 11 0.0008
557 BACTERIAL INFECTION 15 0.0008
558 ORTHOSTATIC HYPOTENSION 14 0.0008
559 BLOOD POTASSIUM INCREASED 13 0.0008
560 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
561 HYPERKALAEMIA 28 0.0008
562 HEPATIC CIRRHOSIS 15 0.0008
563 PAIN IN EXTREMITY 235 0.0008
564 HEART RATE IRREGULAR 18 0.0008
565 AORTIC ANEURYSM 6 0.0008
566 ASTHENIA 294 0.0008
567 ARRHYTHMIA 37 0.0008
568 SKIN REACTION 11 0.0008
569 COAGULOPATHY 13 0.0008
570 PHARYNGEAL OEDEMA 12 0.0008
571 LYMPHOPENIA 11 0.0008
572 SEASONAL ALLERGY 11 0.0008
573 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
574 LUPUS-LIKE SYNDROME 7 0.0008
575 INJECTION SITE INDURATION 10 0.0008
576 FACE OEDEMA 13 0.0008
577 INTESTINAL OBSTRUCTION 29 0.0008
578 THROMBOCYTOPENIA 86 0.0008
579 PULMONARY HYPERTENSION 16 0.0008
580 NODULE 10 0.0008
581 LETHARGY 44 0.0008
582 STEVENS-JOHNSON SYNDROME 17 0.0008
583 PNEUMONIA BACTERIAL 7 0.0008
584 GRAND MAL CONVULSION 7 0.0008
585 MUSCULOSKELETAL DISCOMFORT 13 0.0008
586 HEADACHE 473 0.0008
587 HYPERLIPIDAEMIA 9 0.0008
588 MUSCLE RIGIDITY 9 0.0008
589 CARDIAC FAILURE ACUTE 5 0.0007
590 FOETAL EXPOSURE DURING PREGNANCY 61 0.0007
591 HAEMATEMESIS 19 0.0007
592 TREMOR 124 0.0007
593 OFF LABEL USE 654 0.0007
594 QUALITY OF LIFE DECREASED 10 0.0007
595 HYPOPHAGIA 19 0.0007
596 SPUTUM DISCOLOURED 7 0.0007
597 SHOCK HAEMORRHAGIC 6 0.0007
598 CYTOPENIA 9 0.0007
599 DISORIENTATION 29 0.0007
600 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 52 0.0007
601 CROHN'S DISEASE 5 0.0007
602 ESCHERICHIA INFECTION 6 0.0007
603 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
604 PAIN 447 0.0007
605 STAPHYLOCOCCAL INFECTION 24 0.0007
606 EOSINOPHIL COUNT INCREASED 6 0.0007
607 MUSCLE SPASMS 132 0.0007
608 COORDINATION ABNORMAL 10 0.0007
609 BRAIN OEDEMA 9 0.0007
610 HEPATOMEGALY 7 0.0007
611 LABORATORY TEST ABNORMAL 21 0.0007
612 BLOOD CALCIUM DECREASED 8 0.0007
613 ANKLE FRACTURE 11 0.0007
614 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
615 LUNG INFECTION 11 0.0007
616 ABDOMINAL DISTENSION 73 0.0007
617 BRAIN INJURY 7 0.0007
618 EMPHYSEMA 7 0.0007
619 DEEP VEIN THROMBOSIS 45 0.0007
620 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
621 SKIN SWELLING 6 0.0007
622 RESPIRATORY TRACT INFECTION 18 0.0007
623 CYSTITIS 22 0.0007
624 DYSPNOEA EXERTIONAL 26 0.0007
625 TOOTH ABSCESS 7 0.0007
626 SPINAL OSTEOARTHRITIS 6 0.0007
627 PULMONARY CONGESTION 9 0.0007
628 NASAL CONGESTION 40 0.0007
629 IMMUNOSUPPRESSION 6 0.0007
630 TREATMENT FAILURE 56 0.0007
631 PULMONARY EMBOLISM 64 0.0007
632 HERNIA 13 0.0007
633 TENDERNESS 7 0.0007
634 HAEMATURIA 23 0.0007
635 PULMONARY MASS 10 0.0007
636 MYALGIA 114 0.0007
637 HAEMOLYTIC ANAEMIA 6 0.0007
638 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
639 SKIN FISSURES 13 0.0007
640 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
641 LEUKOPENIA 33 0.0007
642 SKIN DISORDER 22 0.0007
643 BURSITIS 8 0.0007
644 RESTLESSNESS 24 0.0007
645 DISCOMFORT 40 0.0007
646 RESPIRATORY DEPRESSION 8 0.0007
647 CONDITION AGGRAVATED 197 0.0006
648 CONVULSION 37 0.0006
649 HAEMOPTYSIS 18 0.0006
650 THERAPY NON-RESPONDER 29 0.0006
651 PANCYTOPENIA 36 0.0006
652 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 116 0.0006
653 DYSARTHRIA 24 0.0006
654 MULTI-ORGAN FAILURE 11 0.0006
655 GENERAL PHYSICAL HEALTH DETERIORATION 73 0.0006
656 HEPATIC FAILURE 19 0.0006
657 RESPIRATORY TRACT CONGESTION 10 0.0006
658 ADVERSE EVENT 58 0.0006
659 GAIT INABILITY 21 0.0006
660 CARDIOGENIC SHOCK 9 0.0006
661 ATRIAL FLUTTER 5 0.0006
662 METABOLIC ACIDOSIS 20 0.0006
663 RHABDOMYOLYSIS 26 0.0006
664 DRUG EXPOSURE DURING PREGNANCY 21 0.0006
665 ASCITES 18 0.0006
666 WOUND 17 0.0006
667 INABILITY TO AFFORD MEDICATION 6 0.0006
668 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
669 COLON CANCER 9 0.0006
670 CONFUSIONAL STATE 97 0.0006
671 PERICARDITIS 10 0.0006
672 HYPOTHYROIDISM 19 0.0006
673 PRODUCT ADMINISTRATION ERROR 12 0.0006
674 FLUID RETENTION 30 0.0006
675 CHOLECYSTITIS 7 0.0006
676 TREATMENT NONCOMPLIANCE 32 0.0006
677 THROMBOSIS 47 0.0006
678 HELICOBACTER INFECTION 6 0.0006
679 DYSSTASIA 17 0.0006
680 UNEVALUABLE EVENT 44 0.0006
681 MUSCULAR WEAKNESS 66 0.0006
682 PNEUMONIA 188 0.0006
683 FOOT FRACTURE 11 0.0006
684 RASH GENERALISED 15 0.0006
685 ADRENAL INSUFFICIENCY 7 0.0006
686 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
687 ANXIETY 162 0.0006
688 DYSGEUSIA 42 0.0006
689 LYMPHADENOPATHY 20 0.0006
690 HEPATOCELLULAR INJURY 8 0.0006
691 SUBDURAL HAEMATOMA 8 0.0006
692 HYPOGLYCAEMIA 27 0.0006
693 DERMATITIS ALLERGIC 7 0.0006
694 DECREASED ACTIVITY 6 0.0006
695 ABDOMINAL PAIN LOWER 14 0.0006
696 VISION BLURRED 76 0.0006
697 MYELODYSPLASTIC SYNDROME 8 0.0006
698 HYPERTHYROIDISM 8 0.0006
699 LIMB INJURY 15 0.0006
700 WRONG TECHNIQUE IN DRUG USAGE PROCESS 20 0.0005
701 PREGNANCY 11 0.0005
702 MYDRIASIS 7 0.0005
703 GASTROINTESTINAL PAIN 6 0.0005
704 PRODUCT USE IN UNAPPROVED INDICATION 135 0.0005
705 HOT FLUSH 41 0.0005
706 TASTE DISORDER 11 0.0005
707 MEDICATION ERROR 30 0.0005
708 INTENTIONAL PRODUCT USE ISSUE 47 0.0005
709 HAEMORRHAGE 56 0.0005
710 SYSTEMIC LUPUS ERYTHEMATOSUS 19 0.0005
711 APPENDICITIS 5 0.0005
712 INTESTINAL PERFORATION 6 0.0005
713 GASTROOESOPHAGEAL REFLUX DISEASE 43 0.0005
714 EYE INFECTION 6 0.0005
715 INJECTION SITE URTICARIA 13 0.0005
716 BONE PAIN 31 0.0005
717 SEIZURE 61 0.0005
718 MYOCARDIAL ISCHAEMIA 6 0.0005
719 BRONCHITIS 39 0.0005
720 BLOOD URINE PRESENT 10 0.0005
721 ABASIA 13 0.0005
722 SCAB 6 0.0005
723 PROTEINURIA 10 0.0005
724 DERMATITIS 11 0.0005
725 GASTRIC HAEMORRHAGE 6 0.0005
726 BLOOD CREATININE INCREASED 34 0.0005
727 OROPHARYNGEAL PAIN 48 0.0005
728 RENAL FAILURE ACUTE 22 0.0005
729 SINUS CONGESTION 7 0.0005
730 DIZZINESS POSTURAL 5 0.0005
731 MUSCULOSKELETAL PAIN 27 0.0005
732 RHINORRHOEA 33 0.0005
733 BRAIN FOG 8 0.0005
734 MENORRHAGIA 10 0.0005
735 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
736 HEAD DISCOMFORT 9 0.0005
737 DECREASED APPETITE 118 0.0005
738 PLATELET COUNT DECREASED 54 0.0005
739 BLISTER 28 0.0005
740 OSTEOMYELITIS 9 0.0005
741 GAMMA-GLUTAMYLTRANSFERASE INCREASED 11 0.0005
742 DYSPHONIA 29 0.0005
743 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
744 HEPATOTOXICITY 11 0.0005
745 FEEDING DISORDER 10 0.0005
746 DRY THROAT 5 0.0005
747 PANCREATITIS ACUTE 11 0.0005
748 DYSPEPSIA 48 0.0005
749 EAR DISCOMFORT 5 0.0005
750 PRODUCT PREPARATION ERROR 10 0.0005
751 DISEASE RECURRENCE 23 0.0005
752 JAUNDICE 13 0.0005
753 TOOTH LOSS 10 0.0005
754 TOOTH EXTRACTION 6 0.0005
755 EPISTAXIS 36 0.0005
756 BLOOD BILIRUBIN INCREASED 13 0.0005
757 RHEUMATOID ARTHRITIS 54 0.0005
758 DYSPHAGIA 45 0.0005
759 MUSCULOSKELETAL DISORDER 9 0.0005
760 SLEEP APNOEA SYNDROME 9 0.0005
761 DRUG PRESCRIBING ERROR 9 0.0005
762 RESPIRATORY DISORDER 14 0.0005
763 FEELING ABNORMAL 112 0.0005
764 HYPERGLYCAEMIA 17 0.0005
765 DYSURIA 17 0.0005
766 FATIGUE 359 0.0005
767 NERVOUSNESS 24 0.0005
768 RED BLOOD CELL COUNT DECREASED 13 0.0005
769 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
770 ANGINA PECTORIS 13 0.0005
771 FIBROMYALGIA 11 0.0005
772 NEURALGIA 11 0.0005
773 TRANSAMINASES INCREASED 10 0.0004
774 EYE HAEMORRHAGE 6 0.0004
775 CYTOKINE RELEASE SYNDROME 9 0.0004
776 GALLBLADDER DISORDER 8 0.0004
777 ENCEPHALOPATHY 11 0.0004
778 WEIGHT DECREASED 125 0.0004
779 HOSPITALISATION 68 0.0004
780 INFECTION 64 0.0004
781 FLATULENCE 25 0.0004
782 URINARY TRACT INFECTION 75 0.0004
783 MOVEMENT DISORDER 14 0.0004
784 BLOOD POTASSIUM DECREASED 13 0.0004
785 APHASIA 13 0.0004
786 BLOOD TEST ABNORMAL 6 0.0004
787 DRUG LEVEL INCREASED 7 0.0004
788 VIRAL INFECTION 14 0.0004
789 FEMUR FRACTURE 13 0.0004
790 DYSKINESIA 17 0.0004
791 IMPAIRED QUALITY OF LIFE 6 0.0004
792 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
793 POST PROCEDURAL COMPLICATION 8 0.0004
794 CONTUSION 40 0.0004
795 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
796 EMOTIONAL DISTRESS 50 0.0004
797 LIVER FUNCTION TEST ABNORMAL 12 0.0004
798 PAIN OF SKIN 11 0.0004
799 CATARACT 24 0.0004
800 INFLUENZA LIKE ILLNESS 33 0.0004
801 AGEUSIA 10 0.0004
802 SPINAL FRACTURE 8 0.0004
803 SOMNOLENCE 80 0.0004
804 GAIT DISTURBANCE 76 0.0004
805 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
806 OSTEOPENIA 6 0.0004
807 CARDIOVASCULAR DISORDER 10 0.0004
808 VERTIGO 24 0.0004
809 BONE MARROW FAILURE 8 0.0004
810 DIABETES MELLITUS 30 0.0004
811 RENAL IMPAIRMENT 33 0.0004
812 VAGINAL HAEMORRHAGE 17 0.0004
813 CEREBRAL HAEMORRHAGE 14 0.0004
814 NASOPHARYNGITIS 72 0.0004
815 GOUT 7 0.0004
816 TOOTHACHE 7 0.0004
817 CONSTIPATION 84 0.0004
818 FALL 128 0.0004
819 PANIC ATTACK 14 0.0004
820 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
821 INSOMNIA 102 0.0004
822 DEHYDRATION 51 0.0004
823 MUCOSAL INFLAMMATION 10 0.0004
824 BEDRIDDEN 5 0.0004
825 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
826 INJECTION SITE REACTION 26 0.0004
827 FEBRILE NEUTROPENIA 25 0.0004
828 HIP FRACTURE 12 0.0004
829 IRRITABLE BOWEL SYNDROME 8 0.0004
830 HYPONATRAEMIA 21 0.0004
831 POOR QUALITY SLEEP 8 0.0004
832 NEPHROLITHIASIS 17 0.0004
833 THERAPY CESSATION 19 0.0004
834 AGITATION 27 0.0004
835 SKIN EXFOLIATION 31 0.0004
836 ADVERSE DRUG REACTION 33 0.0004
837 OSTEOPOROSIS 15 0.0004
838 CORONARY ARTERY OCCLUSION 5 0.0004
839 SPEECH DISORDER 19 0.0004
840 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
841 PNEUMONIA ASPIRATION 9 0.0004
842 EPILEPSY 11 0.0004
843 OCULAR HYPERAEMIA 17 0.0004
844 NECK PAIN 20 0.0004
845 EYE PRURITUS 12 0.0004
846 CARPAL TUNNEL SYNDROME 5 0.0004
847 KIDNEY INFECTION 7 0.0004
848 PRODUCTIVE COUGH 17 0.0004
849 CANDIDA INFECTION 6 0.0004
850 DISABILITY 7 0.0004
851 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
852 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
853 ABORTION SPONTANEOUS 14 0.0003
854 FULL BLOOD COUNT DECREASED 7 0.0003
855 MUSCLE TWITCHING 8 0.0003
856 LUNG DISORDER 17 0.0003
857 MENTAL DISORDER 15 0.0003
858 DEATH 296 0.0003
859 NEUROTOXICITY 6 0.0003
860 CEREBROVASCULAR ACCIDENT 58 0.0003
861 INJECTION SITE WARMTH 7 0.0003
862 ILLNESS 35 0.0003
863 CARDIOMYOPATHY 5 0.0003
864 NEUROPATHY PERIPHERAL 32 0.0003
865 IMPAIRED HEALING 11 0.0003
866 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
867 MOUTH ULCERATION 7 0.0003
868 WHITE BLOOD CELL COUNT DECREASED 36 0.0003
869 ALOPECIA 65 0.0003
870 INTERSTITIAL LUNG DISEASE 16 0.0003
871 CRYING 12 0.0003
872 FUNGAL INFECTION 11 0.0003
873 BONE DISORDER 6 0.0003
874 ACCIDENTAL OVERDOSE 12 0.0003
875 JOINT INJURY 7 0.0003
876 CEREBRAL INFARCTION 8 0.0003
877 ASTHMA 37 0.0003
878 LIVER INJURY 8 0.0003
879 PROCEDURAL PAIN 9 0.0003
880 NEUTROPENIA 44 0.0003
881 SINUSITIS 33 0.0003
882 PANCREATITIS 17 0.0003
883 HEPATIC FUNCTION ABNORMAL 12 0.0003
884 COGNITIVE DISORDER 15 0.0003
885 NERVOUS SYSTEM DISORDER 10 0.0003
886 NEUTROPHIL COUNT DECREASED 13 0.0003
887 PAIN IN JAW 9 0.0003
888 HEAD INJURY 10 0.0003
889 INCORRECT DOSE ADMINISTERED 72 0.0003
890 COVID-19 55 0.0003
891 SNEEZING 7 0.0003
892 OVERDOSE 67 0.0003
893 DRY MOUTH 25 0.0003
894 INCORRECT ROUTE OF DRUG ADMINISTRATION 11 0.0003
895 SKIN BURNING SENSATION 22 0.0003
896 OSTEOARTHRITIS 13 0.0003
897 CHOLELITHIASIS 10 0.0003
898 TINNITUS 14 0.0003
899 UPPER LIMB FRACTURE 6 0.0003
900 FEAR 8 0.0003
901 WEIGHT INCREASED 66 0.0003
902 PNEUMONITIS 8 0.0003
903 INJECTION SITE SWELLING 22 0.0003
904 DRUG-INDUCED LIVER INJURY 9 0.0003
905 ROAD TRAFFIC ACCIDENT 12 0.0003
906 HALLUCINATION, VISUAL 6 0.0003
907 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
908 RENAL DISORDER 13 0.0003
909 PRODUCT COMPLAINT 7 0.0003
910 MYOCARDIAL INFARCTION 48 0.0003
911 DRUG INEFFECTIVE 360 0.0003
912 COMA 13 0.0003
913 DRUG INTERACTION 43 0.0003
914 URINARY RETENTION 9 0.0003
915 DIPLOPIA 7 0.0003
916 INJECTION SITE PAIN 82 0.0003
917 INJECTION SITE ERYTHEMA 33 0.0003
918 INJECTION SITE BRUISING 21 0.0003
919 DISEASE PROGRESSION 31 0.0003
920 MIGRAINE 25 0.0003
921 INJECTION SITE RASH 8 0.0003
922 DELIRIUM 9 0.0003
923 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
924 CHOKING 5 0.0003
925 INJURY 18 0.0003
926 DIVERTICULITIS 7 0.0003
927 THERAPY INTERRUPTED 18 0.0003
928 MYELOSUPPRESSION 9 0.0002
929 EYE PAIN 14 0.0002
930 STOMATITIS 15 0.0002
931 UNDERDOSE 18 0.0002
932 INTENTIONAL DOSE OMISSION 7 0.0002
933 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
934 HYPERSOMNIA 7 0.0002
935 HERPES ZOSTER 14 0.0002
936 EYE DISORDER 8 0.0002
937 BALANCE DISORDER 21 0.0002
938 OSTEONECROSIS OF JAW 6 0.0002
939 INFLUENZA 27 0.0002
940 EYE SWELLING 9 0.0002
941 DRY SKIN 32 0.0002
942 NO ADVERSE EVENT 42 0.0002
943 LACRIMATION INCREASED 7 0.0002
944 ECZEMA 12 0.0002
945 BLOOD GLUCOSE INCREASED 42 0.0002
946 BLINDNESS 9 0.0002
947 DEPRESSION 50 0.0002
948 LACTIC ACIDOSIS 7 0.0002
949 AMNESIA 14 0.0002
950 TYPE 2 DIABETES MELLITUS 7 0.0002
951 ANGER 7 0.0002
952 PRODUCT STORAGE ERROR 18 0.0002
953 NEOPLASM PROGRESSION 7 0.0002
954 AGGRESSION 10 0.0002
955 HALLUCINATION 15 0.0002
956 SLEEP DISORDER 14 0.0002
957 DRUG ADMINISTRATION ERROR 6 0.0002
958 EMOTIONAL DISORDER 6 0.0002
959 POLLAKIURIA 8 0.0002
960 EAR INFECTION 5 0.0002
961 VISUAL IMPAIRMENT 23 0.0002
962 DISTURBANCE IN ATTENTION 10 0.0002
963 OSTEONECROSIS 6 0.0002
964 MEMORY IMPAIRMENT 25 0.0002
965 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
966 PRODUCT DOSE OMISSION ISSUE 50 0.0002
967 BLOOD GLUCOSE DECREASED 8 0.0002
968 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
969 INJECTION SITE PRURITUS 11 0.0002
970 INJECTION SITE MASS 6 0.0002
971 CARDIAC DISORDER 15 0.0002
972 SURGERY 9 0.0002
973 DRUG EFFECT DECREASED 8 0.0001
974 COMPLETED SUICIDE 12 0.0001
975 DRUG EFFECT INCOMPLETE 5 0.0001
976 IRRITABILITY 8 0.0001
977 SKIN IRRITATION 6 0.0001
978 PROSTATE CANCER 10 0.0001
979 PRODUCT DOSE OMISSION 8 0.0001
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
981 DEVICE DISLOCATION 5 0.0001
982 TOXICITY TO VARIOUS AGENTS 19 0.0001
983 DEVICE DIFFICULT TO USE 7 0.0001
984 ACNE 8 0.0001
985 EYE IRRITATION 6 0.0001
986 DRY EYE 5 0.0001
987 DEPRESSED MOOD 5 0.0001
988 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
989 NEOPLASM MALIGNANT 6 0.0001
990 DEVICE MALFUNCTION 5 0.0001
991 DRUG DEPENDENCE 10 0.0001
992 BREAST CANCER 5 0.0001
993 PSORIASIS 7 0.0001
994 DRUG DOSE OMISSION 6 0.0000